Skip to main content

The Jackson Laboratory Creates Wuhan Cancer Research Facility

Published 6/26/2014

The Jackson Laboratory (JAX) is partnering with Wuhan Frasergen Bioinformatics to create a biomedical research center in Wuhan, China. The facility will support the transfer of basic research to clinical care to provide personalized medicine solutions for cancer and hereditary diseases. JAX's immunocompromised mice will be used as hosts for tumors donated by Chinese patients to enable the development of pharmaceutical therapies.